Detalles de la búsqueda
1.
Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset.
J Immunol
; 208(2): 429-443, 2022 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34903642
2.
Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine.
Clin Immunol
; 237: 108963, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35259543
3.
HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.
J Virol
; 93(6)2019 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30602611
4.
Tim-3 is a Marker of Plasmacytoid Dendritic Cell Dysfunction during HIV Infection and Is Associated with the Recruitment of IRF7 and p85 into Lysosomes and with the Submembrane Displacement of TLR9.
J Immunol
; 198(8): 3181-3194, 2017 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28264968
5.
Corrigendum to "Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine" [Clinical Immunology 237 (2022) 108963].
Clin Immunol
; 251: 109246, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37147236
6.
Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.
J Virol
; 91(16)2017 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28592534
7.
HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection.
J Virol
; 91(8)2017 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28179527
8.
Characterization of cross-reactive CD8+ T-cell recognition of HLA-A2-restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) epitopes in individuals infected with human immunodeficiency and hepatitis C viruses.
J Virol
; 85(1): 254-63, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20980521
9.
HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control.
J Immunol
; 185(1): 498-506, 2010 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20519650
10.
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B.
Sci Adv
; 8(3): eabj9815, 2022 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35044832
11.
HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
Eur J Immunol
; 40(9): 2493-505, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20623550
12.
Neisseria gonorrhoeae effectively blocks HIV-1 replication by eliciting a potent TLR9-dependent interferon-α response from plasmacytoid dendritic cells.
Cell Microbiol
; 12(12): 1703-17, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20735437
13.
Elevated glycolysis imparts functional ability to CD8+ T cells in HIV infection.
Life Sci Alliance
; 4(11)2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34548381
14.
A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies.
Nat Commun
; 12(1): 1806, 2021 03 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33753733
15.
Human immunodeficiency virus type 1 escapes from interleukin-2-producing CD4+ T-cell responses without high-frequency fixation of mutations.
J Virol
; 83(17): 8722-32, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19553327
16.
Trimeric HIV-1 gp140 fused with APRIL, BAFF, and CD40L on the mucosal gp140-specific antibody responses in mice.
Vaccine
; 38(9): 2149-2159, 2020 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32014267
17.
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.
Sci Immunol
; 5(52)2020 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33033173
18.
Virus-specific interleukin-17-producing CD4+ T cells are detectable in early human immunodeficiency virus type 1 infection.
J Virol
; 82(13): 6767-71, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18434403
19.
Pharmacologic HIV-1 Nef blockade promotes CD8 T cell-mediated elimination of latently HIV-1-infected cells in vitro.
JCI Insight
; 2(17)2017 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28878119
20.
Why can't the immune system control HIV-1? Defining HIV-1-specific CD4+ T cell immunity in order to develop strategies to enhance viral immunity.
Immunol Res
; 35(1-2): 89-102, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17003512